Article révisé par les pairs
Résumé : Neoadjuvant chemo-immunotherapy for high-risk triple-negative breast cancer (TNBC) has been shown to reduce the risk of recurrence and improve survival. However, the prognosis for patients with metastatic TNBC remains poor, especially for those with an early recurrence, who represent an urgent unmet need. Defining the most common timing of recurrences after chemo-immunotherapy is crucial for shaping the design of future clinical trials.

Documents en relation

DI-fusion

  • Personalized ctDNA detection and genomic profiling in the NeoRHEA Study.
    par Stanciu, Maria-Alexandra , Agostinetto, Elisa , Papagiannis, Andreas , Pipinikas, Christodoulos P , Chevalier, Amber , Campbell, Nathan , Brandão, Mariana , Ameye, Lieveke , Paesmans, Marianne , Besse, Tatiana , Rothe, Francoise , Buisseret, Laurence , Taylor, Donatienne , Neven, Patrick , Sotiriou, Christos , Duhoux, Francois P , Vuylsteke, Peter , Ignatiadis, Michail
    Publication 2025-12
  • Case report: metachronous male metastatic breast and colon cancer in a BRCA2 mutation carrier
    par Larionesi, Emiliana , Pilet, Oana Nicoleta , Sotiriou, Christos
    Publication 2025-12
  • Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
    par Audisio, Alessandro , Gallio, Chiara , Velenik, Vaneja , Meillat, Hélène , Ruiz-Garcia, Erika , Riesco, Maria Carmen , Alecha, Javier Suárez , Rasschaert, Gertjan , Carvalho, Carlos , Randrian, Violaine , Kirac, Iva , Hernando, Jorge , Artaç, Mehmet , O'Connor, Juan Manuel , Waldhorn, Ithai , Braam, Pètra Manou , Shamseddine, Ali , Moretto, Roberto , De la Pinta, Carolina , De Felice, Francesca , Dulskas, Audrius , Páez López-Bravo, David , Vanden Bulcke, Alexander , Bock, Felix , Deleporte, Amélie , Van Den Eynde, Marc , Geboes, Karen Paula , Loi, Mauro , Messina, Marco , Houlzé-Laroye, Constance , Puccini, Alberto , Pastorino, Alessandro , Papamichael, Demetris , Fiore, Michele , Sur, Daniel , Eid, Michal , Antoun, Claire , Salati, Massimiliano , Garajovà, Ingrid , Jakubauskas, Matas , Tomášek, Jirí , Sousa Pinto, Cidália Maria , Schwingel, Jerome , Morano, Federica , Adams, Richard A , Dermine, Alexandre , Chau, Amélie , Javed, Muhammad Ahsan , Ghidini, Michele , Fiorica, Francesco , Montenegro, Paola , Petrillo, Angelica , Spolverato, Gaya , Mulet Margalef, Núria , Diaz, Marie , Baratelli, Chiara , Puleo, Francesco , Karampeazis, Athanasios , Sert, Fatma , Gilliaux, Quentin , De Stefano, Alfonso , Liberale, Gabriel , Moretti, Luigi , Martinive, Philippe , Deltuvaite Thomas, Vaiva , Staggs, Vincent , Saad, Everardo Delforge , Van Laethem, Jean-Luc , Sclafani, Francesco , International Real-World TNT Study Consortium
    Publication 2025-09-01
  • Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.
    par Papagiannis, Andreas , Majjaj, Samira , Duhoux, Francois P , Agostinetto, Elisa , Stanciu, Maria-Alexandra , Vanhulst, Thila , Buisseret, Laurence , Larsimont, Denis , Veys, Isabelle , Paesmans, Marianne , Hammer, Tatiana Besse , Awada, Ahmad , Ameye, Lieveke , Rothe, Francoise , Madriles, Francesc , Cash, Timothy TP , Salgado, Roberto , Willard-Gallo, Karen , Sotiriou, Christos , Vuylsteke, Peter , Neven, Patrick , Ignatiadis, Michail
    Publication 2025-11
  • PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial.
    par Manley, Martin , Nader-Marta, Guilherme , Ozturk, Ayça Arcay , Kassas, Mutaz , Rothé, Francoise , Taraji, Loubna , Sotiriou, Christos , Wimana, Zéna , Salgado, Roberto , Flamen, Patrick , Gebhart, Géraldine
    Publication 2025-11